ORTHOCELL LIMITED - Announcements

Market Cap $76.49M Add to my watchlist

Healthcare Biotechnology

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	16/07/24	501.91KB	Share
OCC	Regulatory Approval to Commence Sales for Striate in Canada	PRICE SENSITIVE	11/07/24	220.67KB	Share
OCC	Trading Halt	PRICE SENSITIVE	10/07/24	563.84KB	Share
OCC	Pause in Trading	PRICE SENSITIVE	10/07/24	112.67KB	Share
OCC	Record Quarterly and Yearly Revenue Show Outstanding Growth	PRICE SENSITIVE	09/07/24	247.7KB	Share
OCC	Third Revenue Generating Product to be Launched in SmrtGraft	PRICE SENSITIVE	11/06/24	277.81KB	Share
OCC	Outstanding 98.6% Success Rate in Striate Implant Study	PRICE SENSITIVE	14/05/24	261.74KB	Share
OCC	Orthocell receives $3.05m R&D tax incentive refund	PRICE SENSITIVE	15/04/24	198.23KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	08/04/24	591.72KB	Share
OCC	Part 1 Remplir US Market Authorisation Successfully Complete	PRICE SENSITIVE	25/03/24	255.02KB	Share
OCC	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	23/02/24	5.64MB	Share
OCC	Strategic Placement to Raise $3.5 million	PRICE SENSITIVE	22/02/24	209.64KB	Share
OCC	Trading Halt	PRICE SENSITIVE	20/02/24	559.11KB	Share
OCC	Remplir Expansion Continues with Singapore Application	PRICE SENSITIVE	13/02/24	215.05KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	29/01/24	544.01KB	Share
OCC	Successful OrthoATI clinical trial	PRICE SENSITIVE	14/11/23	369.21KB	Share
OCC	UWA Royalty Entitlement Exchanged for Shares in Orthocell	PRICE SENSITIVE	30/10/23	197.39KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	17/10/23	436.76KB	Share
OCC	Appendix 4E & Annual Report	PRICE SENSITIVE	31/08/23	6.17MB	Share
OCC	Striate re-certified under new European medical device regs	PRICE SENSITIVE	24/08/23	187.74KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	31/07/23	619.49KB	Share
OCC	Orthocell receives A$3.17m R&D tax incentive refund	PRICE SENSITIVE	21/06/23	192.17KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	27/04/23	453.45KB	Share
OCC	Orthocell commences nerve repair study	PRICE SENSITIVE	18/04/23	204.15KB	Share
OCC	Leading US-based nerve surgeons appointed to advisory board	PRICE SENSITIVE	29/03/23	169.54KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	4.16MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	30/01/23	456.15KB	Share
OCC	Remplir Gains Australian Reimbursement	PRICE SENSITIVE	01/11/22	299.94KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/22	442.67KB	Share
OCC	OrthoATI Rotator Cuff Study Success With Cross-Over Patients	PRICE SENSITIVE	29/09/22	273.87KB	Share
OCC	First orders for Striate and Remplir	PRICE SENSITIVE	27/09/22	185.26KB	Share
OCC	Appointment of Exclusive Australian Distributor for Remplir	PRICE SENSITIVE	07/09/22	328.63KB	Share
OCC	Trading Halt	PRICE SENSITIVE	06/09/22	564.01KB	Share
OCC	Final Report and Annual Report to Shareholders	PRICE SENSITIVE	31/08/22	5.09MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/07/22	541.28KB	Share
OCC	Striate Global License and Distribution Agreement Update	PRICE SENSITIVE	21/07/22	211.95KB	Share
OCC	OCC Signs Striate Global License And Manufacturing Agreement	PRICE SENSITIVE	27/06/22	205.1KB	Share
OCC	Trading Halt	PRICE SENSITIVE	24/06/22	553.19KB	Share
OCC	Final Data Readout for Orthocells Nerve Reconstruction Study	PRICE SENSITIVE	07/06/22	1.06MB	Share
OCC	Orthocell Receives A$2.1m R&D Tax Incentive Refund	PRICE SENSITIVE	03/06/22	188.36KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/04/22	672.37KB	Share
OCC	Regulatory Approval for Remplir Nerve Repair Device	PRICE SENSITIVE	21/03/22	295.27KB	Share
OCC	Trading Halt	PRICE SENSITIVE	17/03/22	354.77KB	Share
OCC	Pause in Trading	PRICE SENSITIVE	17/03/22	115.43KB	Share
OCC	Striate US Market Entry Update	PRICE SENSITIVE	28/02/22	185.75KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/22	1.18MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/22	728.61KB	Share
OCC	Successful SmrtGraft Shoulder Study Published	PRICE SENSITIVE	16/12/21	239.16KB	Share
OCC	OrthoATI Tendon Clinical Study Success	PRICE SENSITIVE	08/12/21	1.39MB	Share
OCC	Trading Halt	PRICE SENSITIVE	07/12/21	549.94KB	Share
OCC	Ortho-ATI Shoulder Tendon Study Database Lock	PRICE SENSITIVE	15/11/21	220.73KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/10/21	684.82KB	Share
OCC	Positive Data for CelGro Collagen Rope in ACL Reconstruction	PRICE SENSITIVE	15/09/21	712.62KB	Share
OCC	OCC Secures Patents for Suture-Less Repair of Soft Tissue	PRICE SENSITIVE	07/09/21	278.59KB	Share
OCC	Ortho-ATI Shoulder Tendon Study Update Revised	PRICE SENSITIVE	31/08/21	236.6KB	Share
OCC	Ortho-ATI Shoulder Tendon Study Update	PRICE SENSITIVE	31/08/21	222.58KB	Share
OCC	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	27/08/21	4.28MB	Share
OCC	CelGro Facilitates Lymphatic Vessel Regeneration Updated	PRICE SENSITIVE	02/08/21	309.97KB	Share
OCC	CelGro Facilitates Lymphatic Vessel Regeneration	PRICE SENSITIVE	02/08/21	211.45KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	28/07/21	728.61KB	Share
OCC	Orthocell Appoints Exclusive Distributor in Australia	PRICE SENSITIVE	13/07/21	244.78KB	Share
OCC	Positive CelGro Nerve Regeneration Results	PRICE SENSITIVE	21/06/21	365.29KB	Share
OCC	OCC Secures Patents for Sutureless Repair of Soft Tissue	PRICE SENSITIVE	16/06/21	342.86KB	Share
OCC	New Collagen Rope Patent for CelGro Platform Technology	PRICE SENSITIVE	26/05/21	329.46KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	30/04/21	742.77KB	Share
OCC	CelGro Study Results Open Up New US Market Access Strategy	PRICE SENSITIVE	28/04/21	297.55KB	Share
OCC	CelGro gains Australian reimbursement	PRICE SENSITIVE	03/03/21	232.8KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	1.59MB	Share
OCC	Orthocell receives new US patent for CelGro	PRICE SENSITIVE	15/02/21	173.7KB	Share
OCC	CelGro Recommended for Reimbursement	PRICE SENSITIVE	05/02/21	184.61KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/01/21	766.89KB	Share
OCC	Orthocell Receives A$2.3m R&D Tax Incentive Refund	PRICE SENSITIVE	20/01/21	191.85KB	Share
OCC	Orthocell Receives First US CelGro Product Approval	PRICE SENSITIVE	14/01/21	232.56KB	Share
OCC	Trading Halt	PRICE SENSITIVE	12/01/21	355.33KB	Share
OCC	Pause in Trading	PRICE SENSITIVE	12/01/21	114.61KB	Share
OCC	CelGro Receives Australian Market Approval	PRICE SENSITIVE	23/12/20	187.83KB	Share
OCC	CelGro Completes Pivotal Step in TGA Approval Process	PRICE SENSITIVE	17/12/20	216.12KB	Share
OCC	Positive Results in CelGro Nerve Repair Study	PRICE SENSITIVE	20/11/20	295.9KB	Share
OCC	Trading Halt	PRICE SENSITIVE	18/11/20	212.19KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/10/20	930.03KB	Share
OCC	CelGro Bone Regeneration in Dental & Orthopedic Applications	PRICE SENSITIVE	17/09/20	227.62KB	Share
OCC	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	31/08/20	5.84MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/20	445.39KB	Share
OCC	CelGro Nerve Repair AUS Regulatory Application Submitted	PRICE SENSITIVE	30/07/20	196.63KB	Share
OCC	Orthocells Ortho-ATI Shows 87.5% Success Rate	PRICE SENSITIVE	09/07/20	253.93KB	Share
OCC	CelGro US 510(k) Submission Completed	PRICE SENSITIVE	12/05/20	240.65KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	30/04/20	631.86KB	Share
OCC	Successful CelGro US Bone Repair Study	PRICE SENSITIVE	11/03/20	222.92KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/20	1.07MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/20	660.57KB	Share
OCC	US Nerve Repair Study Design Meets FDA Requirements	PRICE SENSITIVE	16/12/19	253.02KB	Share
OCC	SPP Offer Document and Terms And Conditions	PRICE SENSITIVE	05/12/19	704.9KB	Share
OCC	Placement and Share Purchase Plan	PRICE SENSITIVE	04/12/19	265.55KB	Share
OCC	Trading Halt	PRICE SENSITIVE	02/12/19	368.63KB	Share
OCC	New Collagen Rope Patent for CelGro Platform Technology	PRICE SENSITIVE	12/11/19	685KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/19	871.61KB	Share
OCC	CelGro Nerve Regeneration Results in Quadriplegic Patients	PRICE SENSITIVE	09/10/19	946.99KB	Share
OCC	Trading Halt	PRICE SENSITIVE	07/10/19	326.27KB	Share
OCC	Successful CelGro Tendon Regeneration Trial	PRICE SENSITIVE	04/09/19	345.26KB	Share
OCC	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	30/08/19	6.03MB	Share

OCC Quarterly Activity Report & Appendix 4C
16/07/24	PRICE SENSITIVE	501.91KB	Share
OCC Regulatory Approval to Commence Sales for Striate in Canada
11/07/24	PRICE SENSITIVE	220.67KB	Share
OCC Trading Halt
10/07/24	PRICE SENSITIVE	563.84KB	Share
OCC Pause in Trading
10/07/24	PRICE SENSITIVE	112.67KB	Share
OCC Record Quarterly and Yearly Revenue Show Outstanding Growth
09/07/24	PRICE SENSITIVE	247.7KB	Share
OCC Third Revenue Generating Product to be Launched in SmrtGraft
11/06/24	PRICE SENSITIVE	277.81KB	Share
OCC Outstanding 98.6% Success Rate in Striate Implant Study
14/05/24	PRICE SENSITIVE	261.74KB	Share
OCC Orthocell receives $3.05m R&D tax incentive refund
15/04/24	PRICE SENSITIVE	198.23KB	Share
OCC Quarterly Activity Report & Appendix 4C
08/04/24	PRICE SENSITIVE	591.72KB	Share
OCC Part 1 Remplir US Market Authorisation Successfully Complete
25/03/24	PRICE SENSITIVE	255.02KB	Share
OCC Appendix 4D & Half-Year Financial Statements
23/02/24	PRICE SENSITIVE	5.64MB	Share
OCC Strategic Placement to Raise $3.5 million
22/02/24	PRICE SENSITIVE	209.64KB	Share
OCC Trading Halt
20/02/24	PRICE SENSITIVE	559.11KB	Share
OCC Remplir Expansion Continues with Singapore Application
13/02/24	PRICE SENSITIVE	215.05KB	Share
OCC Quarterly Activity Report & Appendix 4C
29/01/24	PRICE SENSITIVE	544.01KB	Share
OCC Successful OrthoATI clinical trial
14/11/23	PRICE SENSITIVE	369.21KB	Share
OCC UWA Royalty Entitlement Exchanged for Shares in Orthocell
30/10/23	PRICE SENSITIVE	197.39KB	Share
OCC Quarterly Activity Report & Appendix 4C
17/10/23	PRICE SENSITIVE	436.76KB	Share
OCC Appendix 4E & Annual Report
31/08/23	PRICE SENSITIVE	6.17MB	Share
OCC Striate re-certified under new European medical device regs
24/08/23	PRICE SENSITIVE	187.74KB	Share
OCC Quarterly Activity Report & Appendix 4C
31/07/23	PRICE SENSITIVE	619.49KB	Share
OCC Orthocell receives A$3.17m R&D tax incentive refund
21/06/23	PRICE SENSITIVE	192.17KB	Share
OCC Quarterly Activity Report & Appendix 4C
27/04/23	PRICE SENSITIVE	453.45KB	Share
OCC Orthocell commences nerve repair study
18/04/23	PRICE SENSITIVE	204.15KB	Share
OCC Leading US-based nerve surgeons appointed to advisory board
29/03/23	PRICE SENSITIVE	169.54KB	Share
OCC Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	4.16MB	Share
OCC Appendix 4C - Quarterly
30/01/23	PRICE SENSITIVE	456.15KB	Share
OCC Remplir Gains Australian Reimbursement
01/11/22	PRICE SENSITIVE	299.94KB	Share
OCC Appendix 4C - Quarterly
31/10/22	PRICE SENSITIVE	442.67KB	Share
OCC OrthoATI Rotator Cuff Study Success With Cross-Over Patients
29/09/22	PRICE SENSITIVE	273.87KB	Share
OCC First orders for Striate and Remplir
27/09/22	PRICE SENSITIVE	185.26KB	Share
OCC Appointment of Exclusive Australian Distributor for Remplir
07/09/22	PRICE SENSITIVE	328.63KB	Share
OCC Trading Halt
06/09/22	PRICE SENSITIVE	564.01KB	Share
OCC Final Report and Annual Report to Shareholders
31/08/22	PRICE SENSITIVE	5.09MB	Share
OCC Appendix 4C - Quarterly
29/07/22	PRICE SENSITIVE	541.28KB	Share
OCC Striate Global License and Distribution Agreement Update
21/07/22	PRICE SENSITIVE	211.95KB	Share
OCC OCC Signs Striate Global License And Manufacturing Agreement
27/06/22	PRICE SENSITIVE	205.1KB	Share
OCC Trading Halt
24/06/22	PRICE SENSITIVE	553.19KB	Share
OCC Final Data Readout for Orthocells Nerve Reconstruction Study
07/06/22	PRICE SENSITIVE	1.06MB	Share
OCC Orthocell Receives A$2.1m R&D Tax Incentive Refund
03/06/22	PRICE SENSITIVE	188.36KB	Share
OCC Appendix 4C - Quarterly
29/04/22	PRICE SENSITIVE	672.37KB	Share
OCC Regulatory Approval for Remplir Nerve Repair Device
21/03/22	PRICE SENSITIVE	295.27KB	Share
OCC Trading Halt
17/03/22	PRICE SENSITIVE	354.77KB	Share
OCC Pause in Trading
17/03/22	PRICE SENSITIVE	115.43KB	Share
OCC Striate US Market Entry Update
28/02/22	PRICE SENSITIVE	185.75KB	Share
OCC Half Yearly Report and Accounts
23/02/22	PRICE SENSITIVE	1.18MB	Share
OCC Appendix 4C - Quarterly
31/01/22	PRICE SENSITIVE	728.61KB	Share
OCC Successful SmrtGraft Shoulder Study Published
16/12/21	PRICE SENSITIVE	239.16KB	Share
OCC OrthoATI Tendon Clinical Study Success
08/12/21	PRICE SENSITIVE	1.39MB	Share
OCC Trading Halt
07/12/21	PRICE SENSITIVE	549.94KB	Share
OCC Ortho-ATI Shoulder Tendon Study Database Lock
15/11/21	PRICE SENSITIVE	220.73KB	Share
OCC Appendix 4C - Quarterly
29/10/21	PRICE SENSITIVE	684.82KB	Share
OCC Positive Data for CelGro Collagen Rope in ACL Reconstruction
15/09/21	PRICE SENSITIVE	712.62KB	Share
OCC OCC Secures Patents for Suture-Less Repair of Soft Tissue
07/09/21	PRICE SENSITIVE	278.59KB	Share
OCC Ortho-ATI Shoulder Tendon Study Update Revised
31/08/21	PRICE SENSITIVE	236.6KB	Share
OCC Ortho-ATI Shoulder Tendon Study Update
31/08/21	PRICE SENSITIVE	222.58KB	Share
OCC Appendix 4E and Annual Report to Shareholders
27/08/21	PRICE SENSITIVE	4.28MB	Share
OCC CelGro Facilitates Lymphatic Vessel Regeneration Updated
02/08/21	PRICE SENSITIVE	309.97KB	Share
OCC CelGro Facilitates Lymphatic Vessel Regeneration
02/08/21	PRICE SENSITIVE	211.45KB	Share
OCC Appendix 4C - Quarterly
28/07/21	PRICE SENSITIVE	728.61KB	Share
OCC Orthocell Appoints Exclusive Distributor in Australia
13/07/21	PRICE SENSITIVE	244.78KB	Share
OCC Positive CelGro Nerve Regeneration Results
21/06/21	PRICE SENSITIVE	365.29KB	Share
OCC OCC Secures Patents for Sutureless Repair of Soft Tissue
16/06/21	PRICE SENSITIVE	342.86KB	Share
OCC New Collagen Rope Patent for CelGro Platform Technology
26/05/21	PRICE SENSITIVE	329.46KB	Share
OCC Appendix 4C - Quarterly
30/04/21	PRICE SENSITIVE	742.77KB	Share
OCC CelGro Study Results Open Up New US Market Access Strategy
28/04/21	PRICE SENSITIVE	297.55KB	Share
OCC CelGro gains Australian reimbursement
03/03/21	PRICE SENSITIVE	232.8KB	Share
OCC Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	1.59MB	Share
OCC Orthocell receives new US patent for CelGro
15/02/21	PRICE SENSITIVE	173.7KB	Share
OCC CelGro Recommended for Reimbursement
05/02/21	PRICE SENSITIVE	184.61KB	Share
OCC Appendix 4C - Quarterly
29/01/21	PRICE SENSITIVE	766.89KB	Share
OCC Orthocell Receives A$2.3m R&D Tax Incentive Refund
20/01/21	PRICE SENSITIVE	191.85KB	Share
OCC Orthocell Receives First US CelGro Product Approval
14/01/21	PRICE SENSITIVE	232.56KB	Share
OCC Trading Halt
12/01/21	PRICE SENSITIVE	355.33KB	Share
OCC Pause in Trading
12/01/21	PRICE SENSITIVE	114.61KB	Share
OCC CelGro Receives Australian Market Approval
23/12/20	PRICE SENSITIVE	187.83KB	Share
OCC CelGro Completes Pivotal Step in TGA Approval Process
17/12/20	PRICE SENSITIVE	216.12KB	Share
OCC Positive Results in CelGro Nerve Repair Study
20/11/20	PRICE SENSITIVE	295.9KB	Share
OCC Trading Halt
18/11/20	PRICE SENSITIVE	212.19KB	Share
OCC Appendix 4C - Quarterly
29/10/20	PRICE SENSITIVE	930.03KB	Share
OCC CelGro Bone Regeneration in Dental & Orthopedic Applications
17/09/20	PRICE SENSITIVE	227.62KB	Share
OCC Appendix 4E and Annual Report to Shareholders
31/08/20	PRICE SENSITIVE	5.84MB	Share
OCC Appendix 4C - Quarterly
31/07/20	PRICE SENSITIVE	445.39KB	Share
OCC CelGro Nerve Repair AUS Regulatory Application Submitted
30/07/20	PRICE SENSITIVE	196.63KB	Share
OCC Orthocells Ortho-ATI Shows 87.5% Success Rate
09/07/20	PRICE SENSITIVE	253.93KB	Share
OCC CelGro US 510(k) Submission Completed
12/05/20	PRICE SENSITIVE	240.65KB	Share
OCC Appendix 4C - Quarterly
30/04/20	PRICE SENSITIVE	631.86KB	Share
OCC Successful CelGro US Bone Repair Study
11/03/20	PRICE SENSITIVE	222.92KB	Share
OCC Half Yearly Report and Accounts
25/02/20	PRICE SENSITIVE	1.07MB	Share
OCC Appendix 4C - Quarterly
31/01/20	PRICE SENSITIVE	660.57KB	Share
OCC US Nerve Repair Study Design Meets FDA Requirements
16/12/19	PRICE SENSITIVE	253.02KB	Share
OCC SPP Offer Document and Terms And Conditions
05/12/19	PRICE SENSITIVE	704.9KB	Share
OCC Placement and Share Purchase Plan
04/12/19	PRICE SENSITIVE	265.55KB	Share
OCC Trading Halt
02/12/19	PRICE SENSITIVE	368.63KB	Share
OCC New Collagen Rope Patent for CelGro Platform Technology
12/11/19	PRICE SENSITIVE	685KB	Share
OCC Appendix 4C - Quarterly
31/10/19	PRICE SENSITIVE	871.61KB	Share
OCC CelGro Nerve Regeneration Results in Quadriplegic Patients
09/10/19	PRICE SENSITIVE	946.99KB	Share
OCC Trading Halt
07/10/19	PRICE SENSITIVE	326.27KB	Share
OCC Successful CelGro Tendon Regeneration Trial
04/09/19	PRICE SENSITIVE	345.26KB	Share
OCC Appendix 4E and Annual Report to Shareholders
30/08/19	PRICE SENSITIVE	6.03MB	Share

REFRESH

1 2

(20min delay)
Last 36.5¢		Change -0.010(2.67%)		Mkt cap ! $76.49M

Open	High	Low	Value	Volume
37.0¢	37.0¢	36.5¢	$9.932K	27.02K

Buyers (Bids)

No.	Vol.	Price($)
2	29838	36.5¢

Sellers (Offers)

Price($)	Vol.	No.
37.5¢	5465	2

View Market Depth

No.	Vol.	Price($)
1	27099	0.365
6	113240	0.360
5	59319	0.355
7	91882	0.350
2	31889	0.345

Price($)	Vol.	No.
0.375	5465	2
0.380	19190	2
0.390	29373	5
0.395	30226	2
0.400	71786	4

Last trade - 14.41pm 23/08/2024 (20 minute delay)


Last 36.5¢		Change -0.010 ( 2.67 %)
Open	High	Low	Volume
37.0¢	37.0¢	36.5¢	21850
Last updated 15.24pm 23/08/2024 ?

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories